APA (7th ed.) Citation

Brightling, C. E., Nair, P., Cousins, D. J., Louis, R., & Singh, D. (2021). Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial. The New England journal of medicine, 385(18), 1669-1679. https://doi.org/10.1056/NEJMoa2030880

Chicago Style (17th ed.) Citation

Brightling, Christopher E., Parameswaran Nair, David J. Cousins, Renaud Louis, and Dave Singh. "Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial." The New England Journal of Medicine 385, no. 18 (2021): 1669-1679. https://doi.org/10.1056/NEJMoa2030880.

MLA (9th ed.) Citation

Brightling, Christopher E., et al. "Risankizumab in Severe Asthma — A Phase 2a, Placebo-Controlled Trial." The New England Journal of Medicine, vol. 385, no. 18, 2021, pp. 1669-1679, https://doi.org/10.1056/NEJMoa2030880.